Cellular metabolism of brevetoxin (PbTx-2) by a monocyte cell line (U-937)

Toxicon

Volumn 53, Issue 1, 2009, Pages 135-145

  Walsh, Catherine J ^a   Leggett, Stephanie R ^a   Henry, Michael S ^b   Blum, Patricia C ^b   Osborn, Shannon ^b   Pierce, Richard H ^b  

^a CENTER FOR SHARK RESEARCH   (United States)

^b MOTE MARINE LABORATORY   (United States)

Author keywords

Brevetoxin; Conjugates; Immunotoxicity; Karenia brevis; Metabolites; PbTx 2; Red tide; U 937

Indexed keywords

BREVETOXIN; GLUTATHIONE;

ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DETOXIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; LIPID OXIDATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MONOCYTE; PRIORITY JOURNAL; PROTEIN DEPLETION;

ANIMALS; CELL LINE; DINOFLAGELLIDA; GLUTATHIONE; HUMANS; MARINE TOXINS; MONOCYTES; TIME FACTORS;

KARENIA BREVIS;

EID: 57749103766     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2008.10.024     Document Type: Article

References (73)

1. Benson J.M., Tischler D.L., and Baden D.G. Uptake and tissue distribution and excretion of brevetoxin 3 administered to rats by intratracheal instillation. J. Toxicol. Environ. Health A 56 (1999) 345-355
2. Benson J., Hahn F., March T., McDonald J., Sopori M., Seagrave J., Gomez A., Bourdelais A., Naar J., Zaias J., Bossart G., and Baden D. Inhalation toxicity of brevetoxin 3 in rats exposed for 5 days. J. Toxicol. Environ. Health A 67 18 (2004) 1443-1456
3. Benson J.M., Hahn F.F., March T.H., McDonald J.D., Gomez A.P., Sopori M.J., Bourdelais A.J., Naar J., Zaias J., Bossart G.D., and Baden D.G. Inhalation toxicity of brevetoxin 3 in rats exposed for twenty-two days. Environ. Health Perspect. 113 5 (2005) 626-631
4. Bossart G.D., Baden D.G., Ewing R., Roberts B., and Wright S. Brevetoxicosis in manatees (Trichechus manatus latirostris) from the 1996 epizootic: gross, histopathologic, and immunocytochemical features. Toxicol. Pathol. 26 2 (1998) 276-282
5. Bottein-Dechraoui M.Y., and Ramsdell J.S. Type B brevetoxins show tissue selectively for voltage-gated sodium channels: comparison of brain, skeletal muscle and cardiac sodium channels. Toxicon 41 7 (2003) 919-927
6. Boverhof D.R., Tam E., Harney A.S., Crawford R.B., Kaminski N.E., and Zacharewski T.R. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells. Mol. Pharmacol. 66 6 (2004) 1662-1670
7. Cheng Y.S., Zhou Y., Irvin C.M., Pierce R.H., Naar J., Backer L.C., Fleming L.E., Kirkpatrick B., and Baden D.G. Characterization of marine aerosol for assessment of human exposure to brevetoxins. Environ. Health Perspect. 113 5 (2005) 638-643
8. D' Angio C.T., LoMonaco M.B., Johnston C.J., Reed C.K., and Finkelstein J.N. Differential roles for NF-κB in endoctoxin and oxygen induction of interleukin-8 in the macrophage. Am. J. Physiol. Lung Cell. Mol. Physiol. 286 (2004) L30-L36
9. Dey A., Parmar D., Dayal M., Dhawan A., and Seth P.K. Cytochrome P450 1A1 (CYP1A1) in blood lymphocytes. Evidence for catalytic activity and mRNA expression. Life Sci. 69 (2001) 383-393
10. Dey A., Parmar D., Dhawan A., Dash D., and Seth P.K. Cytochrome P450 2E1 dependent catalytic activity and lipid peroxidation in rat blood lymphocytes. Life Sci. 71 21 (2002) 2509-2519
11. Dey A., Dhawan A., Kishore Seth P., and Parmar D. Evidence for cytochrome P450 2E1 catalytic activity and expression in rat blood lymphocytes. Life Sci. 77 10 (2005) 1082-1093
12. Dey A., Yadav S., Dhawan A., Seth P.K., and Parmar D. Evidence for cytochrome P450 3A expression and catalytic activity in rat blood lymphocytes. Life Sci. 79 18 (2006) 1729-1735
13. Dröge W., and Holm E. Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction. FASEB J 11 (1997) 1077-1089
14. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
15. Eaton D.L., and Bammler T.K. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol. Sci. 49 2 (1999) 156-164
16. Eisenbrand G., Pool-Zobel B., Baker V., Balls M., Baauboer B.J., Boobis A., Carere A., Kevekordes S., Pieters R., and Kleiner J. Methods of in vitro toxicology. Food Chem. Toxicol. 40 (2002) 193-206
17. Esterbauer H., Zollner H., and Scholz N. Reaction of glutathione with conjugated carbonyls. Z. Naturforsch. [C] 30 4 (1975) 466-473
18. Fernández C., Ramos A.M., Sancho P., Amrán D., de Blas E., and Aller P. 12-O-Tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promoncytic cells. J. Biol. Chem. 270 5 (2004) 3877-3884
19. Fidelus R.K., and Tsan M.F. Glutathione and lymphocyte activation: a function of ageing and auto-immune disease. Immunology 61 4 (1987) 503-508
20. Fleming L.E., Kirkpatrick B., Backer L.C., Bean J.A., Wanner A., Dalpra D., Tamer R., Zaias J., Cheng Y.S., Pierce R., Naar J., Abraham W., Clark R., Zhou Y., Henry M.S., Johnson D., Van de Bogart G., Bossart G.D., Harrington M., and Baden D.G. Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthma. Environ. Health Perspect. 113 5 (2005) 650-657
21. Fleming L.E., Kirkpatrick B., Backer L.C., Bean J.A., Wanner A., Reich A., Zaias J., Cheng Y.S., Pierce R., Naar J., Abraham W.M., and Baden D.G. Aerosolized red-tide toxins (brevetoxins) and asthma. Chest 13 1 (2007) 187-194
22. Fratelli M., Goodwin L.O., Ørom U.A., Lombardi S., Ronelli R., Mengozzi M., and Ghezzi P. Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc. Natl. Acad. Sci. U.S.A. 102 39 (2005) 13998-14003
23. Fuchs J., Zollner T.M., Kaufmann R., and Podda M. Redox-modulated pathways in inflammatory skin diseases. Free Radic. Biol. Med. 30 (2001) 337-353
24. Furukawa M., Nishimura M., Ogino D., Chiba R., Ikai I., Ueda N., Naito S., Kuribayashi S., Moustafa M.S., Uchida T., Sawada H., Kamataki T., Funae Y., and Fukumoto M. Cytochrome P450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver. Cancer Sci. 95 6 (2004) 520-529
25. Gao J., Lauer F.T., Dunaway S., and Burchiel S.W. Cytochrome P450 1B1 is required for 7,12-dimethylbenz(a)-anthracence (DMBA) induced spleen cell immunotoxicity. Toxicol. Sci. 86 1 (2005) 68-74
26. Griffith O.W. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic. Biol. Med. 27 (1999) 922-935
27. Han T.K., Derby M., Martin D.F., Wright S.D., and Dao M.L. Effects of brevetoxins on murine myeloma SP2/O cells: aberrant cellular division. Int. J. Toxicol. 22 (2003) 73-80
28. Hannon-Fletcher M.P., and Barnett Y.A. Lymphocyte cytochrome P450 expression: inducibility studies in male Wistar rats. Br. J. Biomed. Sci. 65 1 (2008) 1-6
29. Hildeman D.A., Mitchell T., Kappler J., and Marrack P. T-cell apoptosis and reactive oxygen species. J. Clin. Invest. 111 (2003) 575-581
30. Jakoby W.B., and Ziegler D.M. The enzymes of detoxication. J. Biol. Chem. 265 34 (1990) 20715-20718
31. Katunuma N., Matsunaga Y., Himeno K., and Hayashi Y. Insights into the roles of cathepsins in antigen processing and presentation revealed by specific inhibitors. Biol. Chem. 384 (2003) 883-890
32. Kim H.J., Baraja B., Chan R.C., and Nel A.E. Glutathione depletion inhibits dendritic cell maturation and delayed-type hypersensitity: implications for systemic disease and immunosenescence. J. Allergy Clin. Immunol. 119 5 (2007) 1225-1233
33. Kirkpatrick B., Fleming L.E., Backer L.C., Bean J.A., Tamer R., Kirkaptrick G., Kane T., Wanner A., Dalpra D., Reich A., and Baden D.G. Environmental exposures to Florida red tides: Effects on emergency room respiratory diagnoses admissions. Harmful Algae 5 (2006) 526-533
34. Koskinen M., and Plna K. Specific DNA adducts induced by some mono-substituted epoxides in vitro and in vivo. Chem. Biol. Interact. 129 3 (2000) 209-229
35. Kreuder C., Mazet J.A.K., Bossart G.D., Carpenter T.E., Holyoak M., Elie M.S., and Wright S.D. Clinicopathologic features of suspected brevetoxicosis in double-crested cormorants (Phalacrocorax auritus) along the Florida Gulf coast. J. Zoo. Wildl. Med. 33 (2002) 8-15
36. Lee M.E., and Urso P. Suppression of T lymphocyte proliferation to antigenic and mitogenic stimuli by benzo(alpha)pyrene and 2-aminofluorene metabolites. Immunopharmacol. Immunotoxicol. 29 3-4 (2007) 425-438
37. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
38. 1 toxicity by using buffalo granulocytes and agranulocytes in vitro. Altern. Lab. Anim. 33 4 (2005) 387-390
39. Pierce R.H., Henry M.S., Blum P.C., Lyons J., Cheng Y.S., Yazzie D., and Zhou Y. Brevetoxin concentrations in marine aerosol: Human exposure levels during a Karenia brevis harmful algal bloom. Bull. Environ. Contam. Toxicol. 70 1 (2003) 161-165
40. Pierce R.H., Henry M.S., Blum P.C., Hamel S.L., Kirkpatrick B., Cheng Y.S., Zhou Y., Irvin C.M., Naar J., Weidner A., Fleming L.E., Backer L.C., and Baden D.G. Brevetoxin composition in water and marine aerosol along a Florida beach: Assessing potential human exposure to marine biotoxins. Harmful Algae 4 6 (2005) 965-972
41. Pierce R., Henry M., and Blum P. Brevetoxin abundance and composition during ECOHAB-Florida field monitoring cruises in the Gulf of Mexico. Continental Shelf Res. 28 (2008) 45-58
42. Plakas S.M., Wang Z., El Said K.R., Jester E.L.E., Granade H.R., Flewelling L., Scott P., and DickeyDickey R.W. Brevetoxin metabolism and elimination in the Easter oyster (Crassostrea virginica) after controlled exposures to Karenia brevis. Toxicon 44 (2004) 677-685
43. Radwan F.F.Y., Wang Z., and Ramsdell J.S. Rapid identification of a rapid detoxification mechanism for brevetoxin in rats. Toxicol. Sci. 85 (2005) 839-846
44. Radwan F.F.Y., and Ramsdell J.S. Characterization of in vitro oxidative and conjugative metabolic pathways for brevetoxin (PbTx-2). Toxicol. Sci. 89 1 (2006) 57-65
45. Radwan F.F.Y., and Ramsdell J.S. Brevetoxin forms covalent DNA adducts in rat lung following intratracheal exposure. Environ. Health Perspect. 116 7 (2008) 930-936
46. Rahman I., Li X.Y., Donaldson K., Harrison D.J., and MacNee W. Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am. J. Physiol. 269 (1995) L285-L292
47. Ramos A.M., Fernández C., Amrán D., Sancho P., de Blas E., and Aller P. Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukmic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells. Blood 105 (2005) 4013-4020
48. Sayer A., Hu Q., Bourdelais A.J., Baden D.G., and Gibson J.E. The effect of brevenal on brevetoxin-induced DNA damage in human lymphocytes. Arch. Toxicol. 79 (2005) 683-688
49. Sayer A.N., Hu Q., Bourdelais A.J., Baden D.G., and Gibson J.E. The inhibition of CHO-K1-BH4 cell proliferation and induction of chromosomal aberrations by brevetoxins in vitro. Food Chem. Toxicol. 44 7 (2006) 1082-1091
50. Scatena R., Messana I., Martorana G.E., Gozzo M.L., Lippa S., Maccaglia A., Bottoni P., Vincenzoni F., Nocca G., Castagnola M., and Giardina B. Mitochondrial damage and metabolic compensatory mechanisms induced by hyperoxia in the U-937 cell line. J. Biochem. Mol. Biol. 37 4 (2004) 454-549
51. Sen C.K. Cellular thiols and redox-regulated signal transduction. Curr. Top. Cell. Regul. 36 (2000) 1-30
52. Siest G., Jeannesson E., Marteau J.B., Samara A., Marie B., Pfister M., and Visvikis-Siest S. Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects. Drug Metab. Dispos. 36 1 (2008) 182-189
53. Srinivasan A., Lehmler H.J., Robertson L.W., and Ludewig G. Production of DNA strand breaks in vitro and reactive oxygen species in vitro and in HL-60 cells by PCB metabolites. Toxicol. Sci. 60 1 (2001) 92-102
54. Sudarsanam S., Virca G.D., March C.J., and Srinivasan S. An approach to computer-aided inhibitor design: application to cathepsin L. J. Comput. Aided Mol. Des. 6 3 (1992) 223-233
55. Sundström C., and Nilsson K. Establishment and characterization of a human lymphoma cell line (U-937). Int. J. Cancer 17 5 (1976) 565-577
56. Tibbetts B.M., Baden D.G., and Benson J.M. Uptake, tissue distribution, and excretion of brevetoxin-3 administered to mice by intratracheal instillation. J. Toxicol. Environ. Health A 69 14 (2006) 1325-1335
57. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal. Biochem. 27 (1969) 502-522
58. Townsend D.M., Tew K.D., and Tapiero H. The importance of glutathione in human disease. Biomed. Pharmacother. 57 (2003) 145-155
59. Troyano A., Fernández C., Sancho P., de Blas E., and Aller P. Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. J. Biol. Chem. 276 50 (2001) 47107-47115
60. Van Duursen M.B.M., Sanderson J.T., and van den Berg M. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility. Toxicol. Sci. 85 (2005) 703-712
61. Walsh C.J., Luer C.A., and Noyes D.R. Effects of environmental stressors on lymphocyte proliferation in the Florida manatee, Trichechus manatus latirostris. Vet. Immunol. Immunopathol. 103 3-4 (2005) 247-256
62. Walsh C.J., Stuckey J.E., Cox H., Smith B., Funke C., Stott J., Colle C., Gaspard J., and Manire C.A. Production of nitric oxide by peripheral blood mononuclear cells from the Florida manatee, Trichechus manatus latirostris. Vet. Immunol. Immunopathol. 118 3-4 (2007) 199-209
63. Walsh C.J., Leggett S.R., Strohbehn K., Pierce R.H., and Sleasman J.W. Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat). Mar. Drugs 6 (2008) 291-307
64. Wang Z., Plakas S.M., El Said K.R., Jester E.L.E., Granade H.R., and Dickey R.W. LC/MS analysis of brevetoxin metabolites in the Eastern oyster (Crassostrea virginica). Toxicon 43 (2004) 455-465
65. Washburn B.S., Baden D.G., Gassman N.J., and Walsh P.J. Brevetoxin: tissue distribution and effect on cytochrome P450 enzymes in fish. Toxicon 32 (1994) 799-805
66. Washburn B.S., Vines C.A., Baden D.G., Hinton D.E., and Walsh P. Differential effects of brevetoxin and beta napthoflavone on xenobiotic metabolizing enzymes in striped bass. Aquat. Toxins 35 (1996) 1-10
67. Woofter R., Dechraoui M.Y., Garthwaite I., Towers N.R., Gordon C.J., Cordova J., and Ramsdell J.S. Measurement of brevetoxin levels by radioimmunoassay of blood collection cards after acute, long-term, and low-dose exposure in mice. Environ. Health Perspect. 111 13 (2003) 1595-1600
68. Woofter R., Brendtro K., and Ramsdell J.S. Uptake and elimination of brevetoxin in blood of striped mullet (Mugil cephalus) after aqueous exposure to Karenia brevis. Environ. Health Perspect. 113 1 (2005) 11-16
69. Woofter R.T., Spiess P.C., and Ramsdell J.S. Distribution of brevetoxin (PbTx-3) in mouse plasma: association with high-density lipoproteins. Environ. Health Perspect. 113 11 (2005) 1491-1496
70. Woofter R.T., and Ramsdell J.S. Distribution of brevetoxin to lipoproteins in human plasma. Toxicon 49 7 (2007) 1010-1018
71. Wu G., Fang Y., Yang S., Lupton J.R., and Turner N.D. Glutathione metabolism and its implications for health. J. Nutr. 134 (2004) 489-492
72. Xiao G.G., Wang M., Li N., Loo J.A., and Nel A.E. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J. Biol. Chem. 278 50 (2003) 50781-50790
73. Yoon S.O., Yun C.H., and Chung A.S. Dose effect of oxidative stress on signal transduction in aging. Mech. Ageing Dev. 123 12 (2002) 1597-1604